- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04339491
Physical Activity During Social Isolation
December 29, 2020 updated by: Saliha Gürdal Karakelle, Istanbul University-Cerrahpasa
What Are the Factors That Affect the Physical Activity Levels of Young Adults During Social Isolation Due to Coronavirus?
The aim of the study is to evaluate the physical activity level and the factors affecting physical activity among young adults who are socially isolated due to coronavirus.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
1206
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey, 34500
- Ozge Ertan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Young Adults from Community Sample
Description
Inclusion Criteria:
- Being between the ages of 18-50
- Being volunteer
Exclusion Criteria:
- Being unable to communicate in Turkish
- Not knowing read and write in Turkish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise Habit and Factors Affecting Exercise Attendance
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
It was created by the researchers due to the fact that the existing surveys could not meet the pandemic period.
It will be questioned whether the participants had exercise habits in the times before the pandemic.
Possible reasons will be questioned according to the positive and negative answers.
The answers of the questions are yes / no and they will not be scored.
Frequency evaluation will be made according to the results obtained.
|
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
IPAQ-SF provides information on walking, moderate and vigorous activities and time spent sitting, within a week.
There are two forms of output from scoring the IPAQ.
Results can be reported in categories (low activity levels, moderate activity levels or high activity levels) or as a continuous variable (MET minutes a week).
MET minutes represent the amount of energy expended carrying out physical activity.
|
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
Exercise Benefits/Barriers Scale
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
It was developed in response to a need for an instrument to determine perceptions of individuals concerning the benefits and barriers to participating in exercise.
The scale, which is a 4-point Likert type, has 4 responses from 4 (strongly agree) to 1 (strongly disagree).
The total score of the scale varies between 43-172.
Higher scores mean that knowing the benefits of exercise and no barrier to exercise.
|
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
The Pittsburgh Sleep Quality Index
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.
It consists of 24 questions, 18 of which are included in the scoring.
Each question is scored between 0-3 and the highest total score is 21.
The high total score indicates poor sleep quality.
|
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
The Hospital Anxiety and Depression Scale
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
A self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety.
The questions of the scale, which is a 4-point Likert type, are scored between 0-3.
The total score is obtained between 0-21.
The high score indicates the presence of depression and anxiety.
|
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: AYSE ZENGIN ALPOZGEN, PhD, Istanbul University-Cerrahpasa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Actual)
May 31, 2020
Study Completion (Actual)
May 31, 2020
Study Registration Dates
First Submitted
April 3, 2020
First Submitted That Met QC Criteria
April 5, 2020
First Posted (Actual)
April 9, 2020
Study Record Updates
Last Update Posted (Actual)
December 30, 2020
Last Update Submitted That Met QC Criteria
December 29, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 30042020-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Isolation
-
University of British ColumbiaVancouver Foundation; Inner-City Women's Initiatives SocietyEnrolling by invitationLoneliness | Social Support | Social IsolationCanada
-
University of California, Los AngelesNot yet recruitingSocial Isolation
-
Maimónides Biomedical Research Institute of CórdobaCompleted
-
McMaster UniversitySocial Sciences and Humanities Research Council of CanadaCompletedSocial IsolationCanada
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
University of PadovaActive, not recruiting
-
Dartmouth-Hitchcock Medical CenterUniversity of Texas at AustinCompleted
-
Bright Vision HospitalSengkang Community Hospital; Outram Community HospitalNot yet recruiting
-
Boston Medical CenterCompleted